Presumed circle area ratio of the prostate in a community-based group of men
- PMID: 19220246
- PMCID: PMC2862567
- DOI: 10.1111/j.1464-410X.2009.08354.x
Presumed circle area ratio of the prostate in a community-based group of men
Abstract
OBJECTIVE To determine the normal values for the presumed circle area ratio (PCAR) in a group of community-based men, and to determine whether PCAR is associated with specific urological outcomes. PATIENTS AND METHODS The study was a cross-sectional analysis among 328 Caucasian men (94% participation) residing in Olmsted County, Minnesota, USA. The PCAR was measured during prostatic ultrasonography. Lower urinary tract symptoms (LUTS) were measured using the American Urologic Association Symptom Index. The peak urinary flow rate was measured by a uroflowmeter, and the postvoid residual volume (PVR) was assessed using the BladderScan(TM) BVM 6500 (Verathon, Bothell, WA, USA). Correlations between PCAR and presence of LUTS, peak urinary flow rate, and PVR were determined using Spearman correlation coefficients. Unadjusted and adjusted odds ratios (ORs) were calculated using logistic regression to determine the associations between PCAR thresholds and categorical urological outcomes. RESULTS The median (interquartile range) PCAR was 0.85 (0.81-0.88). After adjusting for age and total prostate volume, men who had PCARs of >0.90 were more likely to have elevated overall and obstructive symptom scores (OR 2.95, 95% confidence interval 1.39-6.25, and 3.47, 1.63-7.39, respectively). CONCLUSION PCAR might add further information beyond total prostate volume when predicting the development of obstructive LUTS.
Conflict of interest statement
Dr Cynthia Girman is an employee of Merck, and Dr Steven Jacobsen is an employee of Kaiser Permanente.
Similar articles
-
Correlation of ultrasound-estimated bladder weight with ultrasound appearance of the prostate and postvoid residual urine in men with lower urinary tract symptoms.Urology. 1998 May;51(5):722-9. doi: 10.1016/s0090-4295(98)00020-x. Urology. 1998. PMID: 9610585
-
Transrectal ultrasound parameters: presumed circle area ratio and transitional zone area in the evaluation of patients with lower urinary tract symptoms.J Endourol. 1999 May;13(4):317-21. doi: 10.1089/end.1999.13.317. J Endourol. 1999. PMID: 10405914
-
Evaluation of resistive index of the prostate and bladder sonomorphologic parameters as replacements for urodynamics to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Low Urin Tract Symptoms. 2019 May;11(3):163-168. doi: 10.1111/luts.12256. Epub 2019 Feb 22. Low Urin Tract Symptoms. 2019. PMID: 30793849
-
New concept of BPH: PCAR theory.Prostate. 1998 Oct 1;37(2):116-25. doi: 10.1002/(sici)1097-0045(19981001)37:2<116::aid-pros8>3.0.co;2-e. Prostate. 1998. PMID: 9759706 Review.
-
Comprehensive patient evaluation for benign prostatic hyperplasia.Urology. 1998 Apr;51(4A Suppl):13-8. doi: 10.1016/s0090-4295(98)00050-8. Urology. 1998. PMID: 9586591 Review.
Cited by
-
Transrectal Doppler Sonography of Benign Prostatic Enlargement in Nigerian Men.J Med Ultrasound. 2019 May 13;27(4):169-176. doi: 10.4103/JMU.JMU_102_18. eCollection 2019 Oct-Dec. J Med Ultrasound. 2019. PMID: 31867189 Free PMC article.
-
The role of invasive and non-invasive urodynamics in male voiding lower urinary tract symptoms.World J Urol. 2011 Apr;29(2):191-7. doi: 10.1007/s00345-009-0488-8. Epub 2009 Nov 15. World J Urol. 2011. PMID: 19916009 Review.
-
Correlation of Doppler ultrasound resistive index in the prostatic gland with severity of male lower urinary tract symptoms, prostate volume, and concomitant diabetes mellitus.Cent European J Urol. 2023;76(3):199-206. doi: 10.5173/ceju.2023.47. Epub 2023 Jul 13. Cent European J Urol. 2023. PMID: 38045784 Free PMC article.
-
The predictive value of prostate spherical volume ratio in lower urinary tract symptoms and clinical progression of benign prostatic hyperplasia: a retrospective cohort study.Int Urol Nephrol. 2025 Jul;57(7):2023-2032. doi: 10.1007/s11255-024-04355-4. Epub 2025 Jan 15. Int Urol Nephrol. 2025. PMID: 39812965 Free PMC article.
-
Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experience.J Radiat Res. 2013 May;54(3):479-84. doi: 10.1093/jrr/rrs126. Epub 2013 Jan 4. J Radiat Res. 2013. PMID: 23292147 Free PMC article. Clinical Trial.
References
-
- Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474–479. - PubMed
-
- Bosch JL, Bangma CH, Groeneveld FP, Bohnen AM. The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: the Krimpen study. Eur Urol. 2008;53:819–825. - PubMed
-
- St Sauver JL, Jacobson DJ, Girman CJ, Lieber MM, McGree ME, Jacobsen SJ. Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort. J Urol. 2006;175:1018–1022. - PubMed
-
- Watanabe H. New concept of BPH: PCAR theory. Prostate. 1998;37:116–125. - PubMed
-
- Kurita Y, Masuda H, Terada H, Suzuki K, Fujita K. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology. 1998;51:595–600. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials